Top Growth Opportunities in RNA Therapeutics

Top Growth Opportunities in
RNA Therapeutics

From targeting previously untreatable genes to developing smarter delivery systems, RNA innovation is redefining precision medicine, therapeutic reach, and market growth.

Frost & Sullivan’s latest analysis explores the fastest-growing RNA modalities, delivery breakthroughs, and strategic investment trends shaping the future of genetic medicine.

Will your strategy lead the next wave of transformation in RNA therapeutics?

Download the Whitepaper

Disruptive Technologies

Next-generation RNA modalities — Self-amplifying RNA (saRNA), circular RNA (circRNA), small-activating RNA (RNAa), microRNA (miRNA), aptamers — are unlocking targets beyond the reach of small molecules and biologics.

Innovative Business Models

Partnership-driven approaches, licensing, and M&A are accelerating R&D, commercialization, and market expansion.

Rising Competitive Intensity

Tier I biopharma players are entering RNA through high-value alliances and acquisitions, raising the stakes for early innovators.

What’s Inside?

Expanding RNA Modalities: How saRNA, circRNA, RNAa, miRNA, and aptamers are opening new therapeutic frontiers.
Breakthrough Delivery Systems: Platforms like xPhore nanoparticles and Centyrins engineered proteins enabling extrahepatic targeting.
Funding & Partnerships: Over 98% private capital and ~15 billion USD in strategic deal flow powering innovation.
Companies to Action: Profiles of leaders such as Arrowhead Pharmaceuticals, Novartis, Vico Therapeutics, Altamira, and Aro Biotherapeutics.
Future Growth Potential: A USD 500 millon to 1 billion market opportunity emerging over the next five years across North America, Europe, and Asia-Pacific.

Fill in the form to access your exclusive copy now.

Explore RNA Growth Opportunities

Sign up for a complimentary Growth Pipeline Dialog™

A Growth Pipeline Dialog is a structured discussion with our growth experts providing unparalleled technology intelligence and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.

Upon completing the dialog session, you will receive a $1,000 honorarium* as a token of our appreciation, which can be used towards the purchase of our products and services on store.frost.com.